Clincosm LogoSign in Get a demo

Coronavirus Disease 2019 (COVID-19)

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Called ROCURS, to Learn About COVID-19 Related Outcomes in

Active, not recruiting
  • Malignant Solid Tumors
  • +2 more
  • Whippany, New Jersey
    Bayer
Feb 2, 2023

Coronavirus Disease 2019 (COVID-19) Trial in Russian Federation (Raphamin, Placebo)

Recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • Belgorod, Russian Federation
  • +47 more
Jan 20, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • +4 more
  • Cooperstown, New York
  • +10 more
Dec 11, 2022

Coronavirus Disease 2019 (COVID-19) Trial in United Kingdom, United States (AZD7442 (tixagevimab [AZD8895] + cilgavimab

Active, not recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061])
  • Birmingham, Alabama
  • +15 more
Nov 7, 2022

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and

Active, not recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • +2 more
  • SARS-CoV-2 and/or MIS-C Exposure
  • Loma Linda, California
  • +19 more
Sep 22, 2022

Coronavirus Disease 2019 (COVID-19), Healthy Volunteer Trial in Guangzhou, Shanghai (AZD7442 IM, Placebo IM, AZD7442 IV)

Active, not recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • Healthy Volunteer
  • AZD7442 IM
  • +3 more
  • Guangzhou, China
  • +1 more
Jul 27, 2022

Convalescent Plasma for Treatment of Veterans With COVID-19

Completed
  • Coronavirus Disease 2019 (COVID-19)
  • COVID-19 convalescent plasma
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Coronavirus Disease 2019 (COVID-19) Trial in China (600 mg AZD7442 IV, 600mg IV)

Active, not recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • 600 mg AZD7442 IV
  • 600mg placebo IV
  • Baoding, China
  • +13 more
Jul 12, 2022

Study of Adults Vaccinated With AZD1222

Terminated
  • Coronavirus Disease 2019 (COVID-19)
  • None (Observational study)
  • Essen, Germany
    Research Site
Jun 27, 2022

Coronavirus Disease 2019 (COVID-19) Trial in Kigali (Placebo, Prothione™ (6g))

Completed
  • Coronavirus Disease 2019 (COVID-19)
  • Placebo
  • Prothione™ (6g)
  • Kigali, Rwanda
    Rinda Ubuzima
Apr 19, 2022

Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial in United States

Terminated
  • Coronavirus Disease 2019 (COVID-19)
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • anti-CD14
  • +2 more
  • Torrance, California
  • +13 more
Mar 24, 2022

Coronavirus Disease 2019 (COVID-19) Trial in United States (Garadacimab, Factor XIIa Antagonist Monoclonal Antibody, Placebo)

Completed
Has Results
  • Coronavirus Disease 2019 (COVID-19)
  • Garadacimab, Factor XIIa Antagonist Monoclonal Antibody
  • Placebo
  • Bradenton, Florida
  • +13 more
Jan 20, 2022

Coronavirus Disease 2019 (COVID-19) Trial in Adelaide (CSL760)

Terminated
  • Coronavirus Disease 2019 (COVID-19)
  • CSL760
  • Adelaide, Australia
    CMAX Clinical Research
Dec 9, 2021

Coronavirus Disease 2019 (COVID-19) Trial in Christchurch (AK119, Placebo)

Completed
  • Coronavirus Disease 2019 (COVID-19)
  • Christchurch, New Zealand
    Christchurch Clinical Studies Trust
Oct 15, 2021

Coronavirus Disease 2019 (COVID-19) Trial in United States (CD24Fc, Placebo)

Completed
Has Results
  • Coronavirus Disease 2019 (COVID-19)
  • Jacksonville, Florida
  • +9 more
Oct 13, 2021

SARS-CoV-2 Infection, Coronavirus Disease 2019 (COVID-19) Trial (SARS-CoV-2 mRNA Vaccine (CVnCoV), Quadrivalent influenza

Withdrawn
  • SARS-CoV-2 Infection
  • Coronavirus Disease 2019 (COVID-19)
  • SARS-CoV-2 mRNA Vaccine (CVnCoV)
  • +2 more
  • (no location specified)
Aug 4, 2021

Coronavirus Disease 2019 (COVID-19) Trial in Tijuana (Mouthwash and nose rinse with the AgNPs solution, Mouthwashes and nose

Completed
  • Coronavirus Disease 2019 (COVID-19)
  • Mouthwash and nose rinse with the AgNPs solution
  • Mouthwashes and nose rinse in a conventional way
  • Tijuana, Baja California, Mexico
    Tijuana General Hospital
May 18, 2021

Collection of Anti-SARS-CoV-2 Immune Plasma

Completed
  • Coronavirus Disease 2019 (COVID-19)
    • Torrance, California
    • +2 more
    Mar 3, 2021

    COVID-19: Human Epidemiology and Response to SARS-CoV-2

    Completed
    • Coronavirus Disease 2019 (COVID-19)
    • SARS-CoV-2
    • Collection of Biological Samples
    • Symptom and Exposure Surveys
    • Aurora, Colorado
    • +19 more
    Feb 11, 2021

    Severe Coronavirus Disease 2019 in Vitamin D Deficiency

    Completed
    • Coronavirus Disease 2019 (COVID-19)
      • Madrid, Spain
        Hospital Clínico San Carlos
      Jan 29, 2021

      Coronavirus Disease 2019 (COVID-19) Trial (CSL324, Placebo)

      Withdrawn
      • Coronavirus Disease 2019 (COVID-19)
      • CSL324
      • Placebo
      • (no location specified)
      Oct 12, 2020

      Coronavirus Disease 2019 (COVID-19), Pneumonia, Hypoxemia Trial (MK-5475, Placebo)

      Withdrawn
      • Coronavirus Disease 2019 (COVID-19)
      • +2 more
      • (no location specified)
      Aug 12, 2020

      Coronavirus Disease 2019 (COVID-19) Trial in Abu Dhabi (Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC),

      Completed
      • Coronavirus Disease 2019 (COVID-19)
      • Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)
      • COVID-19 standard care
      • Abu Dhabi, United Arab Emirates
        Abu Dhabi Stem Cells Center
      Jul 15, 2020

      Coronavirus Disease 2019 (COVID-19) Trial in Guangzhou (BM-MSCs, Placebo)

      Unknown status
      • Coronavirus Disease 2019 (COVID-19)
      • BM-MSCs
      • Placebo
      • Guangzhou, Guangdong, China
        Guangzhou Institute of Respiratory Health, The First Affiliated
      Apr 13, 2020